The U.S. opioid addiction crisis has been directly linked to aggressive pharmaceutical industry practices, with experts citing corporate profit motives as a key driver. Investigations reveal how drugmakers allegedly minimized addiction risks of prescription painkillers while amplifying their benefits, leading to widespread over-prescription.
Public health advocates accuse companies of prioritizing revenue streams over ethical responsibility, sparking a nationwide public health emergency. “This crisis didn’t happen by accident—it was manufactured through misleading marketing and systemic failures in oversight,” stated a healthcare policy analyst. As addiction rates soar, calls grow for stricter regulations and corporate accountability.
Reference(s):
cgtn.com
